Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity.
[This corrects the article DOI: 10.1371/journal.pone.0237030.].
Saved in:
| Main Authors: | Ryosuke Seki, Akira Ohta, Akira Niwa, Yoshinori Sugimine, Haruna Naito, Tatsutoshi Nakahata, Megumu K Saito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249807&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INDUCED PLURIPOTENT STEM CELL-DERIVED MICROGLIA TO STUDY NLRP3 INFLAMMASOME ACTIVATION IN ALZHEIMER’S DISEASE
by: Aslı Erdoğan, et al.
Published: (2024-10-01) -
Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation.
by: Sandro Trova, et al.
Published: (2023-01-01) -
Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2
by: Leon L. Hsieh, et al.
Published: (2024-10-01) -
Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01) -
The Genetic Polymorphisms of NLRP3 Inflammasome Associated with T Helper Cells in Patients with Multiple Myeloma
by: Xueyun Zhao, et al.
Published: (2018-01-01)